Skip to main content
Signal8

STERIS plc (STE)

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.

Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies

Industry: Medical - Specialties

STERIS plc logo

STERIS plc

NYSE:STEHealthcare
-0.03%$232.15
AH Close$232.15+0.00%vs close
Mkt Cap$22.63B
Float97.23M
O/S97.5M
Inst Own97.3%
SI2.9%
Div Yield1.11%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$22.63B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership97.32%

based on 97.50M shares outstanding

SectorHealthcare
IndustryHealthcare Equipment & Supplies
ExchangeNYSE
CountryUSUS
IPO DateJun 1, 1992
Shares Outstanding97.50M
Float97.23M
Company Overview

STERIS plc provides infection prevention products and services worldwide.

It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services.

It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers.

The company was founded in 1985 and is headquartered in Mentor, Ohio.

Leadership

Daniel A. Carestio

President, Chief Executive Officer & Director

Andrew Xilas

Senior Vice President & GM of Dental

John Adam Zangerle

Senior Vice President, General Counsel & Secretary

Karen L. Burton

Senior Vice President, Chief Financial Officer & Chief Accounting Officer

Independent: 3 of 4 listed

Employees

18K+

Country

US

Sector

Healthcare

Website

steris.com

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
No price targets available
Ratings Distribution
BUY
11
HOLD
2
SELL
0
TOTAL13
Insider Trading
InsiderTypeShares
Burton Karen L profile photoBurton Karen LAutomatic Sell228
Sohi Mohsen profile photoSohi MohsenOption Exercise4.1K
Sohi Mohsen profile photoSohi MohsenSale4.1K
Sohi Mohsen profile photoSohi MohsenOption Exercise4.1K
FELDMANN CYNTHIA L profile photoFELDMANN CYNTHIA LGrant/Award1.5K
Alegria Esther M. profile photoAlegria Esther M.Grant/Award1.5K
Shareholders
97.3%
Institutional
(841)
0.3%
Insiderⓘ
(13)
0.0%
5%+ Owners
(0)
2.4%
Unattributed (incl. retail)ⓘ
Institutional97.3%
Insider0.3%
Unattributed (incl. retail)2.4%
Sources: 13F, Form 4, 13D/13GO/S: 97.5M · as of 4 Aug 2026 · SEC cover page
Insiders & Institutional Holders
52-Week Range
$195.14$269.44
$232.15(50th percentile)
Volume
Average Daily Volume695.91K
564.65K today vs 695.91K avg(-19%)

30d Avg

695.91K

60d Avg

678.24K

90d Avg

700.37K

Earnings
Dividend History
TTM Yield
1.11%
Paid quarterly
Annual (LTM)
$2.58
Latest
$0.6900
Sep 4, 26
5Y Growth
+9.62%
per year
Compliance Status
Loading compliance data...